Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 1;37(5):601-615.
doi: 10.1038/onc.2017.359. Epub 2017 Oct 9.

The Extracellular Matrix Protein Mindin Attenuates Colon Cancer Progression by Blocking Angiogenesis via Egr-1-mediated Regulation

Affiliations

The Extracellular Matrix Protein Mindin Attenuates Colon Cancer Progression by Blocking Angiogenesis via Egr-1-mediated Regulation

L-F Wang et al. Oncogene. .

Abstract

Mindin, a secreted, highly conserved extracellular matrix (ECM) protein, exerts a broad spectrum of effects on the innate immune system. However, its function in colorectal cancer (CRC) progression is not well established, and its upstream regulation mechanisms remain unclear. Contrary to previous reports, this study used two different enzyme-linked immunosorbent assay (ELISA) kits to show that the serum level of mindin was significantly decreased in CRC patients and that this decreased level is more significantly associated with the early stages of the disease. To explore the regulation of mindin, we used a bioinformatics approach to predict potential transcription factors and determined that early growth response factor (Egr)-1 directly regulates mindin expression at the transcriptional level using dual luciferase, chromatin immunoprecipitation (ChIP) DNA and electrophoretic mobility shift assay (EMSA) methods. Egr-1 regulates mindin mRNA and protein expression in CRC cells, and the protein expression of both Egr-1 and mindin was significantly decreased in tumor lesions of patients compared with adjacent control tissues. Mindin is essential for Egr-1-mediated inhibition of endothelial cell tube formation, and mindin inhibits endotheliocyte proliferation, migration and angiogenic sprouts in vitro. Overexpression of mindin suppressed xenograft tumor growth by blocking angiogenesis instead of directly suppressing CRC cell proliferation. Mechanically, mindin inhibits the hypoxia-induced HIF-1a and VEGFA protein expression in CRC cells and the phosphorylation of VEGFR-2 in endothelial cells. The results suggest that the serum level of mindin can be used as a novel biomarker for early detection of CRC and that the Egr-1/mindin axis is a potential therapeutic target for the inhibition of angiogenesis in CRC development.

Similar articles

See all similar articles

Cited by 10 articles

See all "Cited by" articles

References

    1. Nat Immunol. 2004 Jan;5(1):88-97 - PubMed
    1. Cancer Res. 2012 Mar 1;72(5):1051-4 - PubMed
    1. PLoS One. 2012;7(5):e37225 - PubMed
    1. World J Gastroenterol. 2010 Mar 7;16(9):1070-5 - PubMed
    1. World J Gastroenterol. 2014 May 7;20(17 ):5082-6 - PubMed

Publication types

MeSH terms

LinkOut - more resources

Feedback